- Home
- FATE vs IBAC Comparison
FATE vs IBAC Comparison
Compare FATE & IBAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- IBAC
- Stock Information
- Founded
- FATE 2007
- IBAC 2020
- Country
- FATE United States
- IBAC United States
- Employees
- FATE N/A
- IBAC N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- IBAC
- Sector
- FATE Health Care
- IBAC
- Exchange
- FATE Nasdaq
- IBAC Nasdaq
- Market Cap
- FATE 142.4M
- IBAC 159.4M
- IPO Year
- FATE 2013
- IBAC 2024
- Fundamental
- Price
- FATE $1.42
- IBAC $10.21
- Analyst Decision
- FATE Hold
- IBAC
- Analyst Count
- FATE 10
- IBAC 0
- Target Price
- FATE $6.75
- IBAC N/A
- AVG Volume (30 Days)
- FATE 2.1M
- IBAC 5.0K
- Earning Date
- FATE 03-04-2025
- IBAC 01-01-0001
- Dividend Yield
- FATE N/A
- IBAC N/A
- EPS Growth
- FATE N/A
- IBAC N/A
- EPS
- FATE N/A
- IBAC 0.22
- Revenue
- FATE $13,447,000.00
- IBAC N/A
- Revenue This Year
- FATE N/A
- IBAC N/A
- Revenue Next Year
- FATE N/A
- IBAC N/A
- P/E Ratio
- FATE N/A
- IBAC $45.84
- Revenue Growth
- FATE N/A
- IBAC N/A
- 52 Week Low
- FATE $1.04
- IBAC $9.93
- 52 Week High
- FATE $8.83
- IBAC $10.50
- Technical
- Relative Strength Index (RSI)
- FATE 48.76
- IBAC N/A
- Support Level
- FATE $1.43
- IBAC N/A
- Resistance Level
- FATE $1.81
- IBAC N/A
- Average True Range (ATR)
- FATE 0.14
- IBAC 0.00
- MACD
- FATE 0.05
- IBAC 0.00
- Stochastic Oscillator
- FATE 39.06
- IBAC 0.00
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About IBAC IB Acquisition Corp. Common Stock
IB Acquisition Corp is a blank check company.